NovaPeptide
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from NovaPeptide between 19 Mar 2026 and 28 Apr 2026. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).
Finnrick Rating™
Tentative Rating
NovaPeptide
Retatrutide
Tested 4 Samples
Last test 28 Apr 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from NovaPeptide
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
28 Apr 2026
First
19 Mar 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 28 Apr 2026 | View | 30mg | 27.3mg | -9.0% | 99.90% | n/a | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab E | Public | |
| 26 Apr 2026 | View | 20mg | 19.9mg | -0.5% | 99.90% | below LOQ | February 8, 2026 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 19 Mar 2026 | View | 10mg | 8.76mg | -12.4% | 99.90% | n/a | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab E | Public | |
| 19 Mar 2026 | View | 20mg | 19.4mg | -3.0% | 99.90% | n/a | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab E | Public | |